本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

12.04
-0.4500-3.60%
盘后12.040.00000.00%17:20 EDT
成交量:51.76万
成交额:624.11万
市值:16.09亿
市盈率:-6.60
高:12.73
开:12.41
低:11.93
收:12.49
数据加载中...
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/24

重要事件披露

Form 8-K - Current report
2024/04/22

重要事件披露

Form 8-K - Current report
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]